Volume 14, Issue 1 (6-2025)                   2025, 14(1): 13-20 | Back to browse issues page

Ethics code: IR.GUMS.REC.1397.203

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Basirat M, Saeedi H, Soleimani F, Soleimani R, Atrkarroshan Z, Safarzadeh P. Anxiety and Depression in Patients with Head and Neck Cancer Undergoing Radiotherapy and Chemotherapy: Frequency and contributing Factors. Journal title 2025; 14 (1) :13-20
URL: http://3dj.gums.ac.ir/article-1-636-en.html
1- Dental Sciences Research Center, Department of Oral and Maxillofacial Medicine, School of Dentistry, Giulan University of Medical Sciences, Rasht, Iran.
2- Department of Radiology, School of Medicine GI Cancer Screening and Prevention Research Center, Guilan University of Medical Sciences.
3- Dentist, Giulan University of Medical Sciences, Rasht, Iran.
4- Department of Psychiatry, School of Medicine, Giulan University of Medical Sciences, Rasht, Iran.
5- Department of Social Medicine, School of Medicine, Otolaryngology Research Center, Guilan University of Medical Sciences, Rasht, Iran.
6- Department of Oral and Maxillofacial Radiology, School of Dentistry, Guilan University of Medical Sciences, Rasht, Iran. , safarzadeh.roudsari@gmail.com
Abstract:   (182 Views)
Objective: Head and neck cancer (HNC) poses numerous challenges for patients, impacting essential structures in the head and neck area and leading to considerable physical and emotional distress. This study aims to examine the frequency of anxiety and depression in head and neck cancer patients receiving radiotherapy and chemotherapy, as well as to identify the factors that contribute to these psychological issues.
Methods: This cross-sectional study was conducted on 80 patients with clinical and histological confirmation of HNC who visited the oncology clinics for radiotherapy and chemotherapy. A questionnaire that included demographic information and the Hospital Anxiety and Depression Scale (HADS) of patients were completed.  The data were analyzed using SPSS version 18.
Results: Among the patients with head and neck cancer, 26.2% reported experiencing anxiety, 25% of people had borderline anxiety while 18.8% reported experiencing depression and 16.2% of people had borderline depression. Significant associations were identified between anxiety levels and the duration since cancer diagnosis. Depression was more prevalent among patients living in rural areas and those in advanced stages of the illness.
Conclusion: The frequency of anxiety and depression is relatively high among patients with head and neck cancer. Living in a rural area and having advanced-stage cancer were associated with higher depression rates, while the time passed since diagnosis of HNC affected anxiety levels. Considering the impact of this cancer type on quality of life, assessing anxiety and depression frequency in these patients can help guide psychological interventions to improve the patients' well-being.
Full-Text [PDF 1358 kb]   (159 Downloads)    
Type of Study: Original article | Subject: General
Received: 2025/03/8 | Accepted: 2025/07/29 | Published: 2025/06/30

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Journal of Dentomaxillofacial

Designed & Developed by : Yektaweb